{"id":157165,"date":"2026-07-16T10:51:56","date_gmt":"2026-07-16T10:51:56","guid":{"rendered":"https:\/\/pabau.com\/?p=157165"},"modified":"2026-08-17T11:38:55","modified_gmt":"2026-08-17T11:38:55","slug":"icd-10-code-c680","status":"publish","type":"post","link":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c680\/","title":{"rendered":"ICD-10 Code C68.0: Malignant neoplasm of urethra"},"content":{"rendered":"\n<script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"MedicalWebPage\",\"headline\":\"ICD-10 Code C68.0: Malignant neoplasm of urethra\",\"description\":\"ICD-10 Code C68.0 covers malignant neoplasm of urethra (urethral carcinoma). Billable for FY2026, effective October 1, 2025. Coding guidelines, related codes, and CPT pairings.\",\"url\":\"https:\/\/pabau.com\/diagnostic-codes\/icd-10-code-c68-0\/\",\"audience\":{\"@type\":\"MedicalAudience\",\"audienceType\":\"Clinician\"},\"reviewedBy\":{\"@type\":\"Person\",\"name\":\"Dr Vanja Kitanova\",\"jobTitle\":\"Medical Reviewer\",\"affiliation\":{\"@type\":\"Organization\",\"name\":\"Pabau\"},\"knowsAbout\":[\"Medical Coding\",\"Clinical Documentation\",\"Healthcare Billing\",\"Clinical Safety\"],\"sameAs\":\"https:\/\/pabau.com\/blog\/author\/vanja\/\"},\"datePublished\":\"2026-07-07\",\"dateModified\":\"2026-07-07\"}<\/script>\n\n\n        <div id=\"key_takeaways\">\n            <div class=\"header\">\n                                    <img decoding=\"async\" src=\"https:\/\/pabau.com\/wp-content\/uploads\/2025\/12\/Key-Takeaways-Icon.svg\" alt=\"Key Takeaways\" height=\"42\" width=\"42\">\n                                <h3>Key Takeaways<\/h3>\n            <\/div>\n            <div class=\"list\">\n                                                            <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#3D3D46\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p>ICD-10 Code C68.0 describes malignant neoplasm of the urethra, a billable and specific ICD-10-CM diagnosis code.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#3D3D46\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p>The FY2026 edition of C68.0 became effective October 1, 2025, under the standard CMS annual update cycle.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#3D3D46\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p>C68.0 sits within the C64-C68 urinary tract malignancy block and is distinct from bladder cancer (C67) and ureter cancer (C66).<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#3D3D46\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p>Pabau&rsquo;s claims management software supports accurate ICD-10-CM code capture and billing workflows for codes including C68.0.<\/p>\n                        <\/div>\n                                                <\/div>\n        <\/div>\n    \n\n\n<p class=\"wp-block-paragraph\">ICD-10 Code C68.0 is the billable ICD-10-CM diagnosis code for malignant neoplasm of the urethra, used once pathology and physician documentation confirm the urethra as the primary tumor site.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Urethral malignancies account for less than 1% of all urologic cancers, but coders still encounter C68.0 regularly in oncology, urology, and general surgery settings. Misassigning the primary site, for example using C67 for the bladder when the tumor actually starts in the urethra, produces claim errors and incorrect cancer registry staging data.<\/p>\n\n\n\n<figure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\">\n<div class=\"wp-block-embed__wrapper\">\n<iframe title=\"ICD-10 Revisions: Stay Updated or Fall Behind\" width=\"800\" height=\"450\" src=\"https:\/\/www.youtube.com\/embed\/bqAyb-BCA0w?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe>\n<\/div>\n<\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">This reference covers ICD-10 Code C68.0 in full: billable status and validity for FY2026, the clinical distinction of urethral malignancy, includes\/excludes notes, the C68 category hierarchy, commonly paired CPT procedures, sequencing guidance for primary versus secondary malignancy, and the ICD-9-CM crosswalk.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">ICD-10 Code C68.0: Definition and billable status<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">ICD-10 Code C68.0 is the billable ICD-10-CM diagnosis code for malignant neoplasm of the urethra. It is a specific, valid code suitable for use on claims and medical records to indicate a primary urethral malignancy for reimbursement purposes.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Field<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Code<\/td>\n<td style=\"padding:12px 16px;color:#374151\">C68.0<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Full description<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Malignant neoplasm of urethra<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Code type<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Billable \/ Specific<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">ICD-10-CM edition<\/td>\n<td style=\"padding:12px 16px;color:#374151\">FY2026 (2026 edition)<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Effective date<\/td>\n<td style=\"padding:12px 16px;color:#374151\">October 1, 2025<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Parent category<\/td>\n<td style=\"padding:12px 16px;color:#374151\">C68 &#8211; Malignant neoplasm of other and unspecified urinary organs<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Block<\/td>\n<td style=\"padding:12px 16px;color:#374151\">C64-C68 &#8211; Malignant neoplasms of urinary tract<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">7th character required<\/td>\n<td style=\"padding:12px 16px;color:#374151\">No<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<p class=\"wp-block-paragraph\">According to the <a href=\"https:\/\/icd10cmtool.cdc.gov\/\" target=\"_blank\" rel=\"nofollow noopener\">CDC\/NCHS ICD-10-CM tool<\/a>, C68.0 is valid for submission on all claim types that accept ICD-10-CM diagnosis codes. No additional character extension is required beyond the four-character code.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Clinical description: malignant neoplasm of urethra<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The urethra is the tubular structure that carries urine from the bladder to the external urethral orifice. Primary urethral carcinoma arises from the urethral epithelium itself, making it anatomically and clinically distinct from malignancies of the bladder (C67), ureter (C66), or kidney (C64-C65). Coders working in urology and sexual health clinic settings encounter this distinction routinely.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Primary urethral carcinoma is rare, representing fewer than 1% of all genitourinary malignancies according to National Cancer Institute SEER Program data. Histological subtypes include transitional cell carcinoma (most common in the posterior urethra), squamous cell carcinoma (most common in the anterior urethra and in women), and adenocarcinoma.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The subtype split has practical implications for documentation, too. Transitional cell tumors turn up more often in male patients, while squamous cell and adenocarcinoma variants are diagnosed more often in women.<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li><strong>Urethra (C68.0):<\/strong> Primary site is the urethral canal itself<\/li><li><strong>Bladder (C67):<\/strong> Malignancy originates in the bladder wall or trigone; distinct from urethral involvement<\/li><li><strong>Ureter (C66):<\/strong> Malignancy of the muscular tube connecting kidney to bladder<\/li><li><strong>Kidney (C64):<\/strong> Renal parenchymal malignancy; separate anatomical and coding site<\/li><\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">When a urethral tumor extends into the bladder neck or a bladder tumor involves the urethra, the coder must determine the primary site from the pathology report and physician documentation. Assigning C68.0 requires that the urethra is the confirmed origin of the malignancy.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Includes, excludes, and coding notes for C68.0<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The ICD-10-CM tabular list for C68.0 contains specific inclusion and exclusion guidance that governs when this code may or may not be assigned. Reproducing these notes verbatim from the official <a href=\"https:\/\/www.cms.gov\/medicare\/coding-billing\/icd-10-codes\" target=\"_blank\" rel=\"nofollow noopener\">CMS ICD-10-CM code files<\/a> is essential for compliance; paraphrasing exclusion notes can introduce coding errors.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Note type<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Content<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Practical implication<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Includes note (C68 category)<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Malignant neoplasm of urinary organs not elsewhere classified<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Confirms C68 covers organs outside kidney, ureter, and bladder<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Excludes1 (C68.0 code level)<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Malignant neoplasm of urethral orifice of bladder &mdash; code to C67.5<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Do not use C68.0 for tumors of the internal urethral orifice or bladder neck; assign C67.5 instead<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Excludes1 (C68 category)<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Malignant neoplasm of female genitourinary tract NOS (C57.9); malignant neoplasm of male genitourinary tract NOS (C63.9)<\/td>\n<td style=\"padding:12px 16px;color:#374151\">These codes cannot be used simultaneously with C68.0; different anatomical sites<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Coding note<\/td>\n<td style=\"padding:12px 16px;color:#374151\">A code from category C77-C79 (secondary malignancy) should be assigned as an additional code when documenting metastatic spread<\/td>\n<td style=\"padding:12px 16px;color:#374151\">C68.0 alone does not capture metastatic disease; secondary sites require additional codes<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<p class=\"wp-block-paragraph\">Coders should also note that morphology codes from ICD-O-3 (used by cancer registries) are not part of the ICD-10-CM submission set for standard claims. If a practice submits data to a cancer registry, ICD-O-3 morphology coding follows separate rules governed by the National Cancer Institute SEER Program, not the standard ICD-10-CM guidelines used for reimbursement.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">With <a href=\"https:\/\/pabau.com\/blog\/patient-management-software\/\">software for managing patients<\/a>, these diagnoses stay linked to pathology results and surveillance schedules.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Documentation requirements for ICD-10 Code C68.0<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">C68.0 carries a higher documentation bar than many neoplasm codes, because the urethra sits directly next to the bladder neck and the two are easy to conflate on a chart. A claim submitted with C68.0 should be supportable by the following in the medical record:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Pathology or biopsy report<\/strong> confirming malignant histology with the urethra explicitly named as the tissue source, not a general \u00ab\u00a0genitourinary\u00a0\u00bb or \u00ab\u00a0pelvic\u00a0\u00bb label<\/li>\n\n\n\n<li><strong>Physician documentation of primary site<\/strong> that separates the urethral canal from the bladder neck or trigone when a tumor spans both structures, since this is the detail that determines C68.0 versus C67.5<\/li>\n\n\n\n<li><strong>Operative or cystoscopy note<\/strong> describing the tumor&rsquo;s location relative to the internal and external urethral orifices<\/li>\n\n\n\n<li><strong>Staging detail<\/strong> from the pathology report or oncology note, such as tumor depth, nodal involvement, or distant spread, where available. Staging isn&rsquo;t part of the ICD-10-CM code itself, but it informs sequencing decisions and cancer registry reporting<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Ambiguous documentation, such as a chart that alternates between bladder and urethral language for the same lesion, should trigger a physician query before C68.0 is assigned. Getting that query answered before the claim goes out is far less work than correcting a rejected or misclassified claim afterward.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Parent and related ICD-10 codes (C68 category)<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">ICD-10 Code C68.0 sits within the C68 parent category, which covers malignant neoplasms of other and unspecified urinary organs. Understanding the full hierarchy helps coders select the most specific code available and avoid nonspecific fallback codes. The same specificity principle applies across the neoplasm chapter: codes such as C55 also require confirmed primary-site documentation before assignment.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Code<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Description<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Billable<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">C64<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Malignant neoplasm of kidney, except renal pelvis<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Yes<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">C65<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Malignant neoplasm of renal pelvis<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Yes<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">C66<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Malignant neoplasm of ureter<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Yes<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">C67<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Malignant neoplasm of bladder<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Yes (multiple subcodes)<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">C68<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Malignant neoplasm of other and unspecified urinary organs<\/td>\n<td style=\"padding:12px 16px;color:#374151\">No (header code)<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">C68.0<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Malignant neoplasm of urethra<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Yes<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">C68.1<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Malignant neoplasm of paraurethral glands<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Yes<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">C68.8<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Malignant neoplasm of overlapping lesion of urinary organs<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Yes<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">C68.9<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Malignant neoplasm of urinary organ, unspecified<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Yes<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<p class=\"wp-block-paragraph\">C68.9 (unspecified urinary organ) should only be assigned when documentation genuinely cannot specify the site. If the physician identifies the urethra as the primary site, C68.0 is the correct and more specific selection. The parent code C68 is a nonbillable header and must never appear on a claim as the sole diagnosis code.<\/p>\n\n\n        <div id=\"pro_tip\">\n            <div class=\"img\">\n                <svg width=\"42\" height=\"42\" viewBox=\"0 0 42 42\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                    <path fill-rule=\"evenodd\" clip-rule=\"evenodd\"\n                        d=\"M12.6383 19.5238C12.6632 21.2071 12.8734 22.9926 12.0685 24.5523C11.0341 26.8917 8.45076 28.169 7.56292 30.5918C6.63082 33.1061 7.19505 36.185 9.31371 37.9786C10.929 39.5678 13.4183 39.9873 15.6061 39.5463C17.4592 39.073 19.1049 37.8388 19.9706 36.1608C20.781 34.7141 20.7866 32.9904 20.5293 31.3985C20.1006 29.3092 18.3775 27.8705 16.9807 26.362C14.8814 24.1005 14.6684 20.6854 15.595 17.8915C16.4331 15.4768 19.0026 14.2344 20.0425 11.9461C20.7202 10.6769 20.7506 9.20327 20.6068 7.81304C20.1864 5.40098 18.3139 3.23631 15.8716 2.56674C13.9742 2.03969 11.8224 2.30052 10.1739 3.37614C8.70522 4.34688 7.5878 5.86618 7.28356 7.58178C6.76081 9.82981 7.53525 12.2822 9.20307 13.9118C10.7658 15.4741 12.4806 17.2273 12.6383 19.5238Z\"\n                        fill=\"#2BADD4\" \/>\n                    <path fill-rule=\"evenodd\" clip-rule=\"evenodd\"\n                        d=\"M22.7048 19.8387C22.6822 22.3279 24.4507 24.6234 26.7493 25.4682C28.0531 25.961 29.4725 25.9183 30.7989 25.5487C32.0575 24.9955 33.301 24.2237 34.0069 23.0092C34.8384 21.5811 35.2982 19.8286 34.7832 18.2094C34.3611 16.2507 32.8739 14.6541 31.0275 13.9426C28.6736 12.9595 25.8073 13.7942 24.1719 15.7001C23.2022 16.8366 22.6143 18.3326 22.7048 19.8387Z\"\n                        fill=\"#2BADD4\" \/>\n                <\/svg>\n            <\/div>\n            <div class=\"text\">\n                <h3>Pro Tip<\/h3>\n                <p>Check pathology reports before assigning C68.0. When a tumor involves both the urethra and an adjacent structure, review whether C68.8 (overlapping lesion) is more accurate than C68.0. The distinction matters for cancer registry submissions and payer medical necessity review.<\/p>\n            <\/div>\n        <\/div>\n    \n\n\n<h2 class=\"wp-block-heading\">Associated CPT and HCPCS procedure codes<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">When billing urethral malignancy encounters, C68.0 commonly pairs with CPT procedure codes covering urethroscopy, biopsy, and surgical intervention. Pairings are determined by the specific clinical procedure performed, not by the diagnosis alone. Practices using claims management software can map these associations to reduce denials at the code-pairing level.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.pabau.com\/cdn\/attachments\/pulse\/content-engine\/diagnostic_codes\/icd-10-code-c680\/automate-claims-through-healthcode.webp\" alt=\"Automate claims and billing with Pabau\"\/><figcaption class=\"wp-element-caption\"><em>Automate claims and billing with Pabau<\/em><\/figcaption><\/figure>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">CPT Code<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Description<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Clinical context<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">52000<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Cystourethroscopy<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Diagnostic evaluation of urethral lesion<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">52204<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Cystourethroscopy with biopsy<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Tissue sampling to confirm urethral malignancy<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">53220<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Excision or fulguration of carcinoma of urethra<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Surgical removal of urethral malignancy<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">53230<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Excision of urethral diverticulum (female)<\/td>\n<td style=\"padding:12px 16px;color:#374151\">May be associated when diverticulum-related malignancy present<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">53210<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Urethrectomy, total, including cystostomy (female)<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Total removal for invasive urethral carcinoma<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">53215<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Urethrectomy, total, including cystostomy (male)<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Total removal for invasive urethral carcinoma in male patients<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<p class=\"wp-block-paragraph\">These pairings are commonly associated with C68.0 encounters based on AAPC coding references; verify specific code applicability against the current CPT codebook and payer policies before submitting claims. Medical necessity requirements vary by payer. Consult the <a href=\"https:\/\/www.aapc.com\/codes\/icd-10-codes-range\/\" target=\"_blank\" rel=\"nofollow noopener\">AAPC ICD-10-CM code reference<\/a> for crosswalk details.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Coders working urethral malignancy claims may also see HCPCS code A4356 on related encounters, which applies when a urethral clamp is dispensed for post-procedure drainage management.<\/p>\n\n\n        <div id=\"book_a_demo\">\n            <div class=\"left-side\">\n                <div class=\"logo\">\n                    <img decoding=\"async\"\n                        src=\"https:\/\/pabau.com\/wp-content\/uploads\/2026\/01\/Logo.svg\"\n                        alt=\"Logo\"\n                        loading=\"lazy\"\n                    \/>\n                <\/div>\n\n                <h3 class=\"heading\">\n                    Streamline your ICD-10 coding workflow                <\/h3>\n\n                <p class=\"description\">\n                    Pabau helps clinics capture accurate ICD-10-CM diagnosis codes, manage clinical documentation, and submit clean claims &#8211; all from one platform. See how it works for urology and specialist practices.                <\/p>\n\n                <div class=\"button-group\">\n                    <a href=\"\/book-demo\/\" class=\"btn btn-scale-effect btn-cta-color btn-md\">\n                        <span class=\"btn-text\">Book a demo<\/span>\n                        <div class=\"btn-icon btn-icon-right\" aria-hidden=\"true\">\n                            <svg\n                                width=\"14\"\n                                height=\"12\"\n                                viewBox=\"0 0 14 12\"\n                                fill=\"none\"\n                                xmlns=\"http:\/\/www.w3.org\/2000\/svg\"\n                            >\n                                <path\n                                    d=\"M0.75 4.77295C0.335786 4.77295 0 5.10874 0 5.52295C0 5.93716 0.335786 6.27295 0.75 6.27295V5.52295V4.77295ZM13.2803 6.05328C13.5732 5.76039 13.5732 5.28551 13.2803 4.99262L8.50736 0.219648C8.21447 -0.073245 7.73959 -0.073245 7.4467 0.219648C7.15381 0.512542 7.15381 0.987415 7.4467 1.28031L11.6893 5.52295L7.4467 9.76559C7.15381 10.0585 7.15381 10.5334 7.4467 10.8263C7.73959 11.1191 8.21447 11.1191 8.50736 10.8263L13.2803 6.05328ZM0.75 5.52295V6.27295L12.75 6.27295V5.52295V4.77295L0.75 4.77295V5.52295Z\"\n                                    fill=\"currentColor\"\n                                ><\/path>\n                            <\/svg>\n                        <\/div>\n                    <\/a>\n                <\/div>\n            <\/div>\n\n            <div class=\"right-side\">\n                <img decoding=\"async\"\n                    src=\"https:\/\/pabau.com\/wp-content\/uploads\/2026\/01\/Home-Page-Concept-4.webp\"\n                    alt=\"Pabau practice management platform\"\n                    loading=\"lazy\"\n                \/>\n            <\/div>\n        <\/div>\n        \n\n\n<h2 class=\"wp-block-heading\">ICD-10-CM coding guidelines for urethral malignancy<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Sequencing C68.0 correctly requires applying the official <a href=\"https:\/\/www.cms.gov\/files\/document\/fy-2026-icd-10-cm-coding-guidelines.pdf\" target=\"_blank\" rel=\"nofollow noopener\">ICD-10-CM coding guidelines<\/a> for neoplasm classification, maintained jointly by CMS and NCHS. They set specific direction on primary versus secondary malignancy sequencing that applies directly to urethral carcinoma encounters.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Primary malignancy sequencing<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">When the patient presents for treatment or diagnosis of the primary urethral tumor, assign C68.0 as the principal diagnosis. This applies to initial diagnosis encounters, surgical resection encounters, and encounters for chemotherapy or radiation directed at the primary urethral site.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Secondary malignancy sequencing<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">If the patient has active urethral malignancy but presents for treatment of a metastatic site, such as lymph node or distant organ involvement, the secondary malignancy code from category C77-C79 is sequenced as the principal diagnosis. C68.0 is then assigned as an additional code to document the primary site.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Sequencing when primary site is unknown<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">When metastatic disease is documented but the primary site cannot be determined, assign C80.1 (malignant neoplasm, unspecified) as the primary diagnosis code. C68.0 should not be assigned if the urethra has not been confirmed as the origin by pathology or physician documentation.<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li><strong>Active treatment of primary site:<\/strong> C68.0 as principal diagnosis<\/li><li><strong>Treatment of metastatic site, primary known:<\/strong> C77-C79 as principal, C68.0 additional<\/li><li><strong>Encounter for chemotherapy\/radiation (primary site):<\/strong> Z51.0 or Z51.11 as principal, C68.0 additional per encounter-for-treatment sequencing rules<\/li><li><strong>History of urethral malignancy, no current treatment:<\/strong> Z85.5 (personal history of malignant neoplasm of urinary tract) may apply; this code covers the C64-C68 history broadly rather than a bladder-specific subcode, so verify against the current tabular list<\/li><\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">ICD-9-CM to ICD-10-CM crosswalk for C68.0<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Practices migrating historical records or reconciling pre-2015 claims will encounter the ICD-9-CM predecessor codes for urethral malignancy. The General Equivalence Mappings (GEMs) maintained by <a href=\"https:\/\/www.cms.gov\/medicare\/coding-billing\/icd-10-codes\/icd-10-cm-icd-10-pcs-gem-archive\" target=\"_blank\" rel=\"nofollow noopener\">CMS<\/a> provide the authoritative forward and backward mapping. Sibling codes such as C64.1 follow the same crosswalk logic and are worth checking when reconciling legacy records across the C64-C68 block.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">ICD-9-CM Code<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">ICD-9-CM Description<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">ICD-10-CM Equivalent<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Mapping type<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">189.3<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Malignant neoplasm of urethra<\/td>\n<td style=\"padding:12px 16px;color:#374151\">C68.0<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Exact match (forward)<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">188.9<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Malignant neoplasm of bladder, part unspecified<\/td>\n<td style=\"padding:12px 16px;color:#374151\">C67.9 (not C68.0)<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Site-specific; do not map to C68.0<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<p class=\"wp-block-paragraph\">The ICD-9-CM code 189.3 maps directly to C68.0 in the CMS GEMs forward mapping. Coders working with historical records should verify the mapping against official CMS GEM files rather than relying on memory or unofficial crosswalk tools.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Note that ICD-9-CM code 188.5 refers to malignant neoplasm of the bladder neck, which maps to C67.5, not C68.0. The two codes are easy to confuse because they sit next to each other in the legacy tabular list, but they describe different primary sites.<\/p>\n\n\n        <div id=\"pro_tip\">\n            <div class=\"img\">\n                <svg width=\"42\" height=\"42\" viewBox=\"0 0 42 42\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                    <path fill-rule=\"evenodd\" clip-rule=\"evenodd\"\n                        d=\"M12.6383 19.5238C12.6632 21.2071 12.8734 22.9926 12.0685 24.5523C11.0341 26.8917 8.45076 28.169 7.56292 30.5918C6.63082 33.1061 7.19505 36.185 9.31371 37.9786C10.929 39.5678 13.4183 39.9873 15.6061 39.5463C17.4592 39.073 19.1049 37.8388 19.9706 36.1608C20.781 34.7141 20.7866 32.9904 20.5293 31.3985C20.1006 29.3092 18.3775 27.8705 16.9807 26.362C14.8814 24.1005 14.6684 20.6854 15.595 17.8915C16.4331 15.4768 19.0026 14.2344 20.0425 11.9461C20.7202 10.6769 20.7506 9.20327 20.6068 7.81304C20.1864 5.40098 18.3139 3.23631 15.8716 2.56674C13.9742 2.03969 11.8224 2.30052 10.1739 3.37614C8.70522 4.34688 7.5878 5.86618 7.28356 7.58178C6.76081 9.82981 7.53525 12.2822 9.20307 13.9118C10.7658 15.4741 12.4806 17.2273 12.6383 19.5238Z\"\n                        fill=\"#2BADD4\" \/>\n                    <path fill-rule=\"evenodd\" clip-rule=\"evenodd\"\n                        d=\"M22.7048 19.8387C22.6822 22.3279 24.4507 24.6234 26.7493 25.4682C28.0531 25.961 29.4725 25.9183 30.7989 25.5487C32.0575 24.9955 33.301 24.2237 34.0069 23.0092C34.8384 21.5811 35.2982 19.8286 34.7832 18.2094C34.3611 16.2507 32.8739 14.6541 31.0275 13.9426C28.6736 12.9595 25.8073 13.7942 24.1719 15.7001C23.2022 16.8366 22.6143 18.3326 22.7048 19.8387Z\"\n                        fill=\"#2BADD4\" \/>\n                <\/svg>\n            <\/div>\n            <div class=\"text\">\n                <h3>Pro Tip<\/h3>\n                <p>When reviewing pre-2015 records coded to 189.3, confirm the physician&rsquo;s documentation specifically names the urethra as the primary site before mapping forward to C68.0. If the record instead says bladder neck, the correct legacy code is 188.5, which maps to C67.5, not C68.0.<\/p>\n            <\/div>\n        <\/div>\n    \n\n\n<h2 class=\"wp-block-heading\">How Pabau supports ICD-10 diagnostic coding workflows<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Accurate ICD-10 Code C68.0 assignment depends on clean clinical documentation at the point of care. When diagnosis capture is manual or disconnected from billing, coding errors occur earlier in the workflow. Pabau&rsquo;s clinical documentation tools keep diagnosis data structured and accessible throughout the encounter workflow.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.pabau.com\/cdn\/attachments\/pulse\/content-engine\/diagnostic_codes\/icd-10-code-c680\/detailed-client-records-in-pabau.webp\" alt=\"Detailed client records in Pabau\"\/><figcaption class=\"wp-element-caption\"><em>Detailed client records in Pabau<\/em><\/figcaption><\/figure>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n\n\n<p class=\"wp-block-paragraph\">Practices using Pabau can support accurate ICD-10 coding through several connected features:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li><strong>Structured clinical records:<\/strong> Diagnosis fields capture ICD-10-CM codes within the patient record, reducing transcription errors between the encounter note and the claim<\/li><li><strong>Digital intake forms:<\/strong> Pabau&rsquo;s digital intake forms capture relevant clinical history that supports primary site documentation, a key requirement for C68.0 assignment<\/li><li><strong>Claims management:<\/strong> The platform&rsquo;s workflow connects diagnosis codes to procedure codes at the point of claim preparation, making code-pairing errors visible before submission<\/li><li><strong>Compliance-ready records:<\/strong> Maintaining clinic compliance workflows around documentation standards supports audit readiness for high-specificity oncology codes like C68.0<\/li><li><strong>Patient data security:<\/strong> Pabau&rsquo;s approach to patient data security ensures sensitive oncology diagnoses are handled with appropriate access controls<\/li><\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Getting C68.0 coding right<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">C68.0 is a specific, billable code with clear anatomical boundaries that coders must apply carefully to avoid misassignment to adjacent urinary tract sites. Getting the primary site right, applying correct sequencing rules, and pairing with the appropriate CPT procedure code are the three points where errors most often occur with urethral malignancy claims.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pabau&rsquo;s structured clinical record keeps diagnosis capture consistent from initial documentation through claim submission. To see how Pabau handles oncology and specialist billing workflows, <a href=\"https:\/\/pabau.com\/book-demo\/\">book a demo<\/a> with the team.<\/p>\n\n\n        <div id=\"expert_picks\">\n            <div class=\"header\">\n                                    <img decoding=\"async\" src=\"https:\/\/pabau.com\/wp-content\/uploads\/2025\/11\/Expert-Picks.svg\" alt=\"Continue your research\" height=\"42\" width=\"42\">\n                                <h3>Continue your research<\/h3>\n            <\/div>\n            <div class=\"content\">\n                                                            <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#54B2D3\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p><strong>Coding another rare, single-organ malignancy?<\/strong> <a href=\"https:\/\/pabau.com\/diagnostic-codes\/icd-10-code-c33\/\">C33<\/a> walks through the same specificity logic for tracheal cancer.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#54B2D3\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p><strong>Need a size-based excision code for comparison?<\/strong> <a href=\"https:\/\/pabau.com\/procedure-codes\/cpt-code-11644\/\">11644<\/a> covers excision of a malignant skin lesion over 4 cm.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#54B2D3\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p><strong>Looking for another low-incidence primary-site code?<\/strong> <a href=\"https:\/\/pabau.com\/diagnostic-codes\/icd-10-code-c23\/\">C23<\/a> covers malignant neoplasm of the gallbladder, where the same documentation specificity rules apply.<\/p>\n                        <\/div>\n                                                <\/div>\n        <\/div>\n    \n\n\n<h2 class=\"wp-block-heading\">Related ICD-10 codes<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/pabau.com\/diagnostic-codes\/icd-10-code-c61\/\">ICD-10 code for prostate cancer \u2014 C61<\/a><\/li>\n\n\n<li><a href=\"https:\/\/pabau.com\/diagnostic-codes\/icd-10-code-c73\/\">ICD-10 code C73 \u2014 Malignant neoplasm of thyroid gland<\/a><\/li>\n\n\n<li><a href=\"https:\/\/pabau.com\/diagnostic-codes\/icd-10-code-c778\/\">ICD-10 code C77.8 \u2014 Secondary cancer, multiple lymph nodes<\/a><\/li>\n\n\n<li><a href=\"https:\/\/pabau.com\/diagnostic-codes\/icd-10-code-c801\/\">ICD-10 code C80.1 \u2014 Malignant (Primary) Neoplasm, Unspecified<\/a><\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Frequently Asked Questions<\/h2>\n\n\n\n<div class=\"schema-faq wp-block-yoast-faq-block\"><div class=\"schema-faq-section\" id=\"faq-question-1784190211748\"><h3 class=\"schema-faq-question\">What is ICD-10 Code C68.0?<\/h3> <p class=\"schema-faq-answer\">ICD-10 Code C68.0 is the billable ICD-10-CM diagnosis code for malignant neoplasm of the urethra. It is a specific code used to indicate a primary urethral carcinoma for reimbursement and clinical documentation purposes. The FY2026 edition became effective October 1, 2025.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1784190211749\"><h3 class=\"schema-faq-question\">Is C68.0 a billable ICD-10-CM code?<\/h3> <p class=\"schema-faq-answer\">Yes, C68.0 is a billable and specific ICD-10-CM code valid for submission on claims. No 7th character extension is required. It can be used as a standalone diagnosis code when the urethra is confirmed as the primary malignancy site.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1784190211750\"><h3 class=\"schema-faq-question\">What is the difference between C67 and C68.0?<\/h3> <p class=\"schema-faq-answer\">C67 covers malignant neoplasm of the bladder; C68.0 covers malignant neoplasm of the urethra. These are distinct anatomical sites with separate code assignments. Assign C68.0 only when the pathology report and physician documentation confirm the urethra as the primary site, not the bladder wall or trigone.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1784190211751\"><h3 class=\"schema-faq-question\">What CPT codes are associated with C68.0?<\/h3> <p class=\"schema-faq-answer\">Commonly associated CPT codes include 52000 (cystourethroscopy), 52204 (cystourethroscopy with biopsy), 53220 (excision or fulguration of urethral carcinoma), 53210 (total urethrectomy, female), and 53215 (total urethrectomy, male). Verify against current CPT guidelines and payer policies before submitting.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1784190211752\"><h3 class=\"schema-faq-question\">When did the 2026 ICD-10-CM edition become effective?<\/h3> <p class=\"schema-faq-answer\">The FY2026 ICD-10-CM edition became effective October 1, 2025, following the standard CMS annual update cycle. This applies to all encounters on or after that date. For official verification, consult the CMS ICD-10 codes page.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1784190211753\"><h3 class=\"schema-faq-question\">How is urethral cancer coded differently from bladder cancer?<\/h3> <p class=\"schema-faq-answer\">Urethral cancer uses C68.0; bladder cancer uses codes from the C67 category (C67.0-C67.9 depending on bladder site). The distinction requires pathological confirmation of the primary tumor origin. When a lesion involves both sites, C68.8 (overlapping lesion of urinary organs) may be more appropriate than either individual site code.<\/p> <\/div> <\/div>\n","protected":false},"excerpt":{"rendered":"<p>ICD-10 Code C68.0 is the billable ICD-10-CM diagnosis code for malignant neoplasm of the urethra, used once pathology and physician documentation confirm the urethra as the primary tumor site. Urethral malignancies account for less than 1% of all urologic cancers, but coders still encounter C68.0 regularly in oncology, urology, and general surgery settings. Misassigning the [&hellip;]<\/p>\n","protected":false},"author":77,"featured_media":157164,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_yoast_wpseo_linkdex":"88","_yoast_wpseo_content_score":"90","_yoast_wpseo_is_cornerstone":"","_yoast_wpseo_keywordsynonyms":"[\"\",\"\",\"\",\"\"]","_yoast_wpseo_focuskw_text_input":"","_seo_original_html":"","footnotes":""},"categories":[1549,1550],"tags":[1680,1363],"class_list":["post-157165","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-diagnostic-codes","category-icd-10-cm","tag-diagnostic-codes","tag-icd-10"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.2 (Yoast SEO v28.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>ICD-10 Code C68.0: Malignant neoplasm of urethra<\/title>\n<meta name=\"description\" content=\"C68.0 is the billable ICD-10-CM code for malignant neoplasm of the urethra. Confirm urethral origin over bladder neck before assigning it.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c680\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ICD-10 Code C68.0: Malignant neoplasm of urethra\" \/>\n<meta property=\"og:description\" content=\"C68.0 is the billable ICD-10-CM code for malignant neoplasm of the urethra. Confirm urethral origin over bladder neck before assigning it.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c680\/\" \/>\n<meta property=\"og:site_name\" content=\"Pabau\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Pabau\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-16T10:51:56+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-17T11:38:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/pabau.com\/wp-content\/uploads\/2026\/07\/icd-10-code-c680.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Katy Piper\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@pabaucrm\" \/>\n<meta name=\"twitter:site\" content=\"@pabaucrm\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Katy Piper\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"11 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c680\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c680\\\/\"},\"author\":{\"name\":\"Katy Piper\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/#\\\/schema\\\/person\\\/5de22f4ff3ec59b1925ef02dce956d7d\"},\"headline\":\"ICD-10 Code C68.0: Malignant neoplasm of urethra\",\"datePublished\":\"2026-07-16T10:51:56+00:00\",\"dateModified\":\"2026-08-17T11:38:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c680\\\/\"},\"wordCount\":2361,\"publisher\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c680\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/icd-10-code-c680.webp\",\"keywords\":[\"Diagnostic codes\",\"ICD-10\"],\"articleSection\":[\"Diagnostic Codes\",\"ICD-10-CM\"],\"inLanguage\":\"fr-FR\"},{\"@type\":[\"WebPage\",\"FAQPage\"],\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c680\\\/\",\"url\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c680\\\/\",\"name\":\"ICD-10 Code C68.0: Malignant neoplasm of urethra\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c680\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c680\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/icd-10-code-c680.webp\",\"datePublished\":\"2026-07-16T10:51:56+00:00\",\"dateModified\":\"2026-08-17T11:38:55+00:00\",\"description\":\"C68.0 is the billable ICD-10-CM code for malignant neoplasm of the urethra. Confirm urethral origin over bladder neck before assigning it.\",\"mainEntity\":[{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c680\\\/#faq-question-1784190211748\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c680\\\/#faq-question-1784190211749\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c680\\\/#faq-question-1784190211750\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c680\\\/#faq-question-1784190211751\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c680\\\/#faq-question-1784190211752\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c680\\\/#faq-question-1784190211753\"}],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c680\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c680\\\/#primaryimage\",\"url\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/icd-10-code-c680.webp\",\"contentUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/icd-10-code-c680.webp\",\"width\":1200,\"height\":630},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/pabau.com\\\/fr\\\/\",\"name\":\"Pabau\",\"description\":\"Clinic Software for your Business | Go Paperless Today\",\"publisher\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pabau.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/#organization\",\"name\":\"Pabau\",\"url\":\"https:\\\/\\\/pabau.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/Logo-4-e1654525062364.png\",\"contentUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/Logo-4-e1654525062364.png\",\"width\":736,\"height\":195,\"caption\":\"Pabau\"},\"image\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/Pabau\\\/\",\"https:\\\/\\\/x.com\\\/pabaucrm\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/pabau-ltd\\\/\",\"https:\\\/\\\/www.instagram.com\\\/pabausoftware\\\/\"],\"description\":\"Pabau is an all-in-one healthcare practice management software platform designed for clinics, medspas, therapists, and medical professionals. It combines scheduling, electronic health records, clinical forms, payments, marketing automation, reporting, and patient engagement tools into one secure cloud system to help practices streamline operations and grow their business.\",\"foundingDate\":\"2011-10-20\",\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":\"201\",\"maxValue\":\"500\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/#\\\/schema\\\/person\\\/5de22f4ff3ec59b1925ef02dce956d7d\",\"name\":\"Katy Piper\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/cropped-Snip20260306_177-96x96.png\",\"url\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/cropped-Snip20260306_177-96x96.png\",\"contentUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/cropped-Snip20260306_177-96x96.png\",\"caption\":\"Katy Piper\"},\"description\":\"Katy Piper is a content writer covering aesthetics, dermatology, and clinic operations, with a knack for making clinical detail feel approachable. Outside of work, she's usually chasing her border collie around muddy fields or hunting down the best flat white in town.\",\"url\":\"https:\\\/\\\/pabau.com\\\/fr\\\/blog\\\/author\\\/katy-piper\\\/\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c680\\\/#faq-question-1784190211748\",\"position\":1,\"url\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c680\\\/#faq-question-1784190211748\",\"name\":\"What is ICD-10 Code C68.0?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"ICD-10 Code C68.0 is the billable ICD-10-CM diagnosis code for malignant neoplasm of the urethra. It is a specific code used to indicate a primary urethral carcinoma for reimbursement and clinical documentation purposes. The FY2026 edition became effective October 1, 2025.\",\"inLanguage\":\"fr-FR\"},\"inLanguage\":\"fr-FR\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c680\\\/#faq-question-1784190211749\",\"position\":2,\"url\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c680\\\/#faq-question-1784190211749\",\"name\":\"Is C68.0 a billable ICD-10-CM code?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Yes, C68.0 is a billable and specific ICD-10-CM code valid for submission on claims. No 7th character extension is required. It can be used as a standalone diagnosis code when the urethra is confirmed as the primary malignancy site.\",\"inLanguage\":\"fr-FR\"},\"inLanguage\":\"fr-FR\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c680\\\/#faq-question-1784190211750\",\"position\":3,\"url\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c680\\\/#faq-question-1784190211750\",\"name\":\"What is the difference between C67 and C68.0?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"C67 covers malignant neoplasm of the bladder; C68.0 covers malignant neoplasm of the urethra. These are distinct anatomical sites with separate code assignments. Assign C68.0 only when the pathology report and physician documentation confirm the urethra as the primary site, not the bladder wall or trigone.\",\"inLanguage\":\"fr-FR\"},\"inLanguage\":\"fr-FR\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c680\\\/#faq-question-1784190211751\",\"position\":4,\"url\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c680\\\/#faq-question-1784190211751\",\"name\":\"What CPT codes are associated with C68.0?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Commonly associated CPT codes include 52000 (cystourethroscopy), 52204 (cystourethroscopy with biopsy), 53220 (excision or fulguration of urethral carcinoma), 53210 (total urethrectomy, female), and 53215 (total urethrectomy, male). Verify against current CPT guidelines and payer policies before submitting.\",\"inLanguage\":\"fr-FR\"},\"inLanguage\":\"fr-FR\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c680\\\/#faq-question-1784190211752\",\"position\":5,\"url\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c680\\\/#faq-question-1784190211752\",\"name\":\"When did the 2026 ICD-10-CM edition become effective?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The FY2026 ICD-10-CM edition became effective October 1, 2025, following the standard CMS annual update cycle. This applies to all encounters on or after that date. For official verification, consult the CMS ICD-10 codes page.\",\"inLanguage\":\"fr-FR\"},\"inLanguage\":\"fr-FR\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c680\\\/#faq-question-1784190211753\",\"position\":6,\"url\":\"https:\\\/\\\/pabau.com\\\/fr\\\/diagnostic-codes\\\/icd-10-code-c680\\\/#faq-question-1784190211753\",\"name\":\"How is urethral cancer coded differently from bladder cancer?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Urethral cancer uses C68.0; bladder cancer uses codes from the C67 category (C67.0-C67.9 depending on bladder site). The distinction requires pathological confirmation of the primary tumor origin. When a lesion involves both sites, C68.8 (overlapping lesion of urinary organs) may be more appropriate than either individual site code.\",\"inLanguage\":\"fr-FR\"},\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"ICD-10 Code C68.0: Malignant neoplasm of urethra","description":"C68.0 is the billable ICD-10-CM code for malignant neoplasm of the urethra. Confirm urethral origin over bladder neck before assigning it.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c680\/","og_locale":"fr_FR","og_type":"article","og_title":"ICD-10 Code C68.0: Malignant neoplasm of urethra","og_description":"C68.0 is the billable ICD-10-CM code for malignant neoplasm of the urethra. Confirm urethral origin over bladder neck before assigning it.","og_url":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c680\/","og_site_name":"Pabau","article_publisher":"https:\/\/www.facebook.com\/Pabau\/","article_published_time":"2026-07-16T10:51:56+00:00","article_modified_time":"2026-08-17T11:38:55+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/07\/icd-10-code-c680.webp","type":"image\/webp"}],"author":"Katy Piper","twitter_card":"summary_large_image","twitter_creator":"@pabaucrm","twitter_site":"@pabaucrm","twitter_misc":{"\u00c9crit par":"Katy Piper","Dur\u00e9e de lecture estim\u00e9e":"11 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c680\/#article","isPartOf":{"@id":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c680\/"},"author":{"name":"Katy Piper","@id":"https:\/\/pabau.com\/fr\/#\/schema\/person\/5de22f4ff3ec59b1925ef02dce956d7d"},"headline":"ICD-10 Code C68.0: Malignant neoplasm of urethra","datePublished":"2026-07-16T10:51:56+00:00","dateModified":"2026-08-17T11:38:55+00:00","mainEntityOfPage":{"@id":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c680\/"},"wordCount":2361,"publisher":{"@id":"https:\/\/pabau.com\/fr\/#organization"},"image":{"@id":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c680\/#primaryimage"},"thumbnailUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/07\/icd-10-code-c680.webp","keywords":["Diagnostic codes","ICD-10"],"articleSection":["Diagnostic Codes","ICD-10-CM"],"inLanguage":"fr-FR"},{"@type":["WebPage","FAQPage"],"@id":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c680\/","url":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c680\/","name":"ICD-10 Code C68.0: Malignant neoplasm of urethra","isPartOf":{"@id":"https:\/\/pabau.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c680\/#primaryimage"},"image":{"@id":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c680\/#primaryimage"},"thumbnailUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/07\/icd-10-code-c680.webp","datePublished":"2026-07-16T10:51:56+00:00","dateModified":"2026-08-17T11:38:55+00:00","description":"C68.0 is the billable ICD-10-CM code for malignant neoplasm of the urethra. Confirm urethral origin over bladder neck before assigning it.","mainEntity":[{"@id":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c680\/#faq-question-1784190211748"},{"@id":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c680\/#faq-question-1784190211749"},{"@id":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c680\/#faq-question-1784190211750"},{"@id":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c680\/#faq-question-1784190211751"},{"@id":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c680\/#faq-question-1784190211752"},{"@id":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c680\/#faq-question-1784190211753"}],"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c680\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c680\/#primaryimage","url":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/07\/icd-10-code-c680.webp","contentUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/07\/icd-10-code-c680.webp","width":1200,"height":630},{"@type":"WebSite","@id":"https:\/\/pabau.com\/fr\/#website","url":"https:\/\/pabau.com\/fr\/","name":"Pabau","description":"Clinic Software for your Business | Go Paperless Today","publisher":{"@id":"https:\/\/pabau.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pabau.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/pabau.com\/fr\/#organization","name":"Pabau","url":"https:\/\/pabau.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/pabau.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/pabau.com\/wp-content\/uploads\/2022\/05\/Logo-4-e1654525062364.png","contentUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2022\/05\/Logo-4-e1654525062364.png","width":736,"height":195,"caption":"Pabau"},"image":{"@id":"https:\/\/pabau.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Pabau\/","https:\/\/x.com\/pabaucrm","https:\/\/www.linkedin.com\/company\/pabau-ltd\/","https:\/\/www.instagram.com\/pabausoftware\/"],"description":"Pabau is an all-in-one healthcare practice management software platform designed for clinics, medspas, therapists, and medical professionals. It combines scheduling, electronic health records, clinical forms, payments, marketing automation, reporting, and patient engagement tools into one secure cloud system to help practices streamline operations and grow their business.","foundingDate":"2011-10-20","numberOfEmployees":{"@type":"QuantitativeValue","minValue":"201","maxValue":"500"}},{"@type":"Person","@id":"https:\/\/pabau.com\/fr\/#\/schema\/person\/5de22f4ff3ec59b1925ef02dce956d7d","name":"Katy Piper","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/03\/cropped-Snip20260306_177-96x96.png","url":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/03\/cropped-Snip20260306_177-96x96.png","contentUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/03\/cropped-Snip20260306_177-96x96.png","caption":"Katy Piper"},"description":"Katy Piper is a content writer covering aesthetics, dermatology, and clinic operations, with a knack for making clinical detail feel approachable. Outside of work, she's usually chasing her border collie around muddy fields or hunting down the best flat white in town.","url":"https:\/\/pabau.com\/fr\/blog\/author\/katy-piper\/"},{"@type":"Question","@id":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c680\/#faq-question-1784190211748","position":1,"url":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c680\/#faq-question-1784190211748","name":"What is ICD-10 Code C68.0?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"ICD-10 Code C68.0 is the billable ICD-10-CM diagnosis code for malignant neoplasm of the urethra. It is a specific code used to indicate a primary urethral carcinoma for reimbursement and clinical documentation purposes. The FY2026 edition became effective October 1, 2025.","inLanguage":"fr-FR"},"inLanguage":"fr-FR"},{"@type":"Question","@id":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c680\/#faq-question-1784190211749","position":2,"url":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c680\/#faq-question-1784190211749","name":"Is C68.0 a billable ICD-10-CM code?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Yes, C68.0 is a billable and specific ICD-10-CM code valid for submission on claims. No 7th character extension is required. It can be used as a standalone diagnosis code when the urethra is confirmed as the primary malignancy site.","inLanguage":"fr-FR"},"inLanguage":"fr-FR"},{"@type":"Question","@id":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c680\/#faq-question-1784190211750","position":3,"url":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c680\/#faq-question-1784190211750","name":"What is the difference between C67 and C68.0?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"C67 covers malignant neoplasm of the bladder; C68.0 covers malignant neoplasm of the urethra. These are distinct anatomical sites with separate code assignments. Assign C68.0 only when the pathology report and physician documentation confirm the urethra as the primary site, not the bladder wall or trigone.","inLanguage":"fr-FR"},"inLanguage":"fr-FR"},{"@type":"Question","@id":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c680\/#faq-question-1784190211751","position":4,"url":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c680\/#faq-question-1784190211751","name":"What CPT codes are associated with C68.0?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Commonly associated CPT codes include 52000 (cystourethroscopy), 52204 (cystourethroscopy with biopsy), 53220 (excision or fulguration of urethral carcinoma), 53210 (total urethrectomy, female), and 53215 (total urethrectomy, male). Verify against current CPT guidelines and payer policies before submitting.","inLanguage":"fr-FR"},"inLanguage":"fr-FR"},{"@type":"Question","@id":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c680\/#faq-question-1784190211752","position":5,"url":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c680\/#faq-question-1784190211752","name":"When did the 2026 ICD-10-CM edition become effective?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"The FY2026 ICD-10-CM edition became effective October 1, 2025, following the standard CMS annual update cycle. This applies to all encounters on or after that date. For official verification, consult the CMS ICD-10 codes page.","inLanguage":"fr-FR"},"inLanguage":"fr-FR"},{"@type":"Question","@id":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c680\/#faq-question-1784190211753","position":6,"url":"https:\/\/pabau.com\/fr\/diagnostic-codes\/icd-10-code-c680\/#faq-question-1784190211753","name":"How is urethral cancer coded differently from bladder cancer?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Urethral cancer uses C68.0; bladder cancer uses codes from the C67 category (C67.0-C67.9 depending on bladder site). The distinction requires pathological confirmation of the primary tumor origin. When a lesion involves both sites, C68.8 (overlapping lesion of urinary organs) may be more appropriate than either individual site code.","inLanguage":"fr-FR"},"inLanguage":"fr-FR"}]}},"yoast":{"focus_keyword":"ICD-10 Code C68.0","seo_title":"ICD-10 Code C68.0: Malignant neoplasm of urethra","meta_description":"C68.0 is the billable ICD-10-CM code for malignant neoplasm of the urethra. Confirm urethral origin over bladder neck before assigning it.","content_score":"90","is_cornerstone":"","related_keyphrases":[{"keyword":"C68 icd 10 code","score":93},{"keyword":"urethral carcinoma diagnosis code","score":61},{"keyword":"malignant neoplasm urinary tract icd 10","score":56}]},"_links":{"self":[{"href":"https:\/\/pabau.com\/fr\/wp-json\/wp\/v2\/posts\/157165","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pabau.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pabau.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pabau.com\/fr\/wp-json\/wp\/v2\/users\/77"}],"replies":[{"embeddable":true,"href":"https:\/\/pabau.com\/fr\/wp-json\/wp\/v2\/comments?post=157165"}],"version-history":[{"count":3,"href":"https:\/\/pabau.com\/fr\/wp-json\/wp\/v2\/posts\/157165\/revisions"}],"predecessor-version":[{"id":181647,"href":"https:\/\/pabau.com\/fr\/wp-json\/wp\/v2\/posts\/157165\/revisions\/181647"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pabau.com\/fr\/wp-json\/wp\/v2\/media\/157164"}],"wp:attachment":[{"href":"https:\/\/pabau.com\/fr\/wp-json\/wp\/v2\/media?parent=157165"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pabau.com\/fr\/wp-json\/wp\/v2\/categories?post=157165"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pabau.com\/fr\/wp-json\/wp\/v2\/tags?post=157165"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}